GeneDx Holdings Corp. Interest Income (Expense), Nonoperating, Net
GeneDx Holdings Corp. (WGS) reported Interest Income (Expense), Nonoperating, Net of -$1.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-03
- GeneDx Holdings Corp. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was -$1.19M.
- GeneDx Holdings Corp. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was -$717.00K.
- GeneDx Holdings Corp. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was -$520.00K.
- GeneDx Holdings Corp. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was -$562.00K.
- GeneDx Holdings Corp. interest income (expense), nonoperating, net for fiscal 2025 was -$2.54M.
- GeneDx Holdings Corp. interest income (expense), nonoperating, net for fiscal 2024 was -$3.03M, a 372.17% decline from fiscal 2023.
- GeneDx Holdings Corp. interest income (expense), nonoperating, net for fiscal 2023 was $1.11M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.19M 10-Q · filed 2026-08-03 | -$1.90M 10-Q · filed 2026-08-03 | -$2.42M derived: sum of 3 quarters · filed 2026-08-03 | -$2.98M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$717.00K 10-Q · filed 2026-05-04 | -$1.24M derived: sum of 2 quarters · filed 2026-05-04 | -$1.80M derived: sum of 3 quarters · filed 2026-05-04 | -$2.62M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$520.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$1.08M derived: sum of 2 quarters · filed 2026-02-23 | -$1.90M derived: sum of 3 quarters · filed 2026-08-03 | -$2.54M 10-K · filed 2026-02-23 |
| 2025-09-30 | -$562.00K 10-Q · filed 2025-10-28 | -$1.38M derived: sum of 2 quarters · filed 2026-08-03 | -$2.02M 10-Q · filed 2025-10-28 | -$2.72M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$817.00K 10-Q · filed 2026-08-03 | -$1.46M 10-Q · filed 2026-08-03 | -$2.15M derived: sum of 3 quarters · filed 2026-08-03 | -$3.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$640.00K 10-Q · filed 2026-05-04 | -$1.34M derived: sum of 2 quarters · filed 2026-05-04 | -$2.18M derived: sum of 3 quarters · filed 2026-05-04 | -$3.08M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$698.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$1.54M derived: sum of 2 quarters · filed 2026-02-23 | -$2.44M derived: sum of 3 quarters · filed 2026-02-23 | -$3.03M 10-K · filed 2026-02-23 |
| 2024-09-30 | -$843.00K 10-Q · filed 2025-10-28 | -$1.74M derived: sum of 2 quarters · filed 2025-10-28 | -$2.33M 10-Q · filed 2025-10-28 | -$3.31M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | -$894.00K 10-Q · filed 2025-07-29 | -$1.49M 10-Q · filed 2025-07-29 | -$2.47M derived: sum of 3 quarters · filed 2026-02-23 | -$1.42M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | -$597.00K 10-Q · filed 2025-04-30 | -$1.57M derived: sum of 2 quarters · filed 2026-02-23 | -$522.00K derived: sum of 3 quarters · filed 2026-02-23 | $552.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | -$978.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $75.00K derived: sum of 2 quarters · filed 2026-02-23 | $1.15M derived: sum of 3 quarters · filed 2026-02-23 | $1.11M 10-K · filed 2026-02-23 |
| 2023-09-30 | $1.05M 10-Q · filed 2024-10-29 | $2.13M derived: sum of 2 quarters · filed 2024-10-29 | $2.09M 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $1.07M 10-Q · filed 2024-07-30 | $1.04M 10-Q · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |